z-logo
Premium
Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre‐S and S genes
Author(s) -
Suwannakarn Kamol,
Tangkijvanich Pisit,
Thawornsuk Nutchanart,
Theamboonlers Apiradee,
Tharmaphornpilas Piyanit,
Yoocharoen Pornsak,
Chongsrisawat Voranush,
Poovorawan Yong
Publication year - 2008
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/j.1872-034x.2007.00254.x
Subject(s) - hbsag , hepatitis b virus , genotype , virology , biology , mutation , hepatitis b , gene , virus , medicine , genetics
Aims:  This study was undertaken to determine the prevalence and characteristics of hepatitis B virus (HBV) genotypes, antigen subtypes, “a” determinant variants and pre‐S gene mutations circulating on a large scale in Thailand. Methods:  The sequences of the Pre‐S1 , Pre‐S2 and S regions were determined in serum samples of 147 HBsAg and HBV DNA‐positive subjects who had been enrolled from the nationwide seroepidemiological survey conducted on 6213 individuals in 2004. Results:  The results showed that genotypes C, B and A accounted for 87.1%, 11.6% and 1.3%, respectively. The distribution of the HBV antigen subtypes was: adr (84.4%), adw (14.2%) and ayw (1.4%). Regarding the “a” determinant, 2/43 (4.65%) and 2/104 (1.92%) samples of vaccinated and non‐vaccinated subjects, respectively, displayed mutations, all ofwhich were Thr126Asn. Sequencing analysis showed the pre‐S mutations in 14 (9.5%) samples, with pre‐S2 deletion as the most common mutant (4.1%) followed by pre‐S2 start codon mutation (2.9%), both pre‐S2 deletion and start codon mutation (2.0%), and pre‐S1 deletion (0.7%). The pre‐S mutations were associated with older age and higher mean serum HBsAg level. Conclusion:  This study demonstrated that HBV genotype/subtype C/adr and B/adw were the predominant strains circulating in Thailand. The “a” determinant variants seemed to be uncommon, and might not be attributed to vaccine‐induced mutation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here